Aurinia Pharmaceuticals (AUPH) Says Phase IIb AURA-LV Study in LN Met Remission Endpoints
Tweet Send to a Friend
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced top-line results from its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
